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Hepatic Effects of Phthalate Esters
by Prahlad K. Seth*
Di(2-ethylhexyl) phthalate (DEHP), acommonlyusedplasticizerandmicrochemical environmental
pollutant, produces subtle changes in hepatic function asjudged by increase in liver weight and
morphological and biochemical alterations. It can modify the biological response of drugs and
other xenobiotics. Such interactions appear to occur at the pharmacokinetic phase, as DEHP
wasfoundtoaltertheactivityofmicrosomaldrug-metabolizingenzymesandethanolmetabolism.
DEHP produced a time- and route-dependent effect on the hepatic cytochrome P-450 contents
and activity of aminopyrine N-demethylase, aniline hydroxylase, alcohol dehydrogenase and
high and lowKm aldehyde dehydrogenases when given orally or intraperitoneally. Under in vitro
conditions, DEHP produced no effect on the activity of aminopyrine N-demethylase or aniline
hydroxylase, whilemono(2-ethylhexyl) phthalate (MEHP) and2-ethylhexanol (2-EH) significantly
inhibited their activity at concentrations ranging from 2.5 to 15.0 mM. Activity of aminopyrine
N-demethylase and aniline hydroxylase was also inhibited by dimethyl phthalate (DMP) and
dibutyl phthalate (DBP) after a single oral administration. In view of the possibility of the
human exposure to phthalates and other xenobiotics simultaneously, these observations are of
great significance.
Introduction
Phthalic acid esters (PAEs) are commonly used
as plasticizers to impart flexibility to plastics,
particularly poly(vinyl chloride) (PVC) polymers,
which have a wide variety of biomedical and other
uses. Di(2-ethylhexyl) phthalate (DEHP) and other
PAEs are known to leach out from finished PVC
productsintoblood, physiologicalfluids, commercial
solvents and food materials (1, 2). Entry of these
plasticizers into the biological system during tran-
fusions (blood orphysiological fluids) orhemodialysis
orthrough food chain and their ubiquitous presence
in environment has led to numerous studies ontheir
toxicology. In spite of their low order of toxicity,
DEHP and other phthalates have been shown to
exert hepatotoxic, cytotoxic, teratogenic and muta-
genic effects. Certain renal, pulmonary and repro-
ductive dysfunctions have also been reported on
exposuretotheseplasticizersinaquaticinvertebrates
and mammalian species (1-3). Liver and testis
appear to be the main target organs in phthalate
toxicity.
It is well established that the biological response
of xenobiotics can be altered significantly due to
their interactions with variables in external and
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internalenvironmental andpharmacological agents.
Unfortunately, this aspect ofphthalate toxicity has
not been studied in detail, though such information
will be of great significance in assessing the
toxicogenic potential of PAEs because of their
ubiquityandhepatotoxicnature. Thispapertherefore
reviews some of the hepatic effects of PAEs, with
particular emphasis on their interaction with drugs
and other xenobiotics.
Effect of Phthalates on Weight,
Morphology and Chemical
Constituents of Liver
Severalinvestigatorshavestudiedthehepatotoxic
potential of PAEs in a variety of animal species.
Acute and chronic administration of DEHP caused
variable effects onliver, dependinguponthe species
of the animal (4). In general, phthalates after oral
orintraperitonealadministration causedenlargement
ofthe liver (5-9), which declined to or below normal
weight on prolonged or discontinued exposure (10)
(Table 1).
Histopathologicalexaminationofphthalate-induced
enlarged livers showed fatty vacuolation and con-
gestion followed by a cloudy swelling, excessive
fatty degeneration (4, 11). Dilatation of smooth
and rough endoplasmic reticulum, mitochondrialTable 1. Effect of DEHP on weight, morphology and chemical constituents of liver.
Route of
Species administration Principal findings References
Rat IP Liver enlargement; no change in dry weight, moisture, pyruvic acid and lactic acid (9)
contents
Rat Oral Liver enlargement (5,6,8)
Rat Oral Liver enlargement, which disappears on prolonged or discontinued exposure (10)
Rat Oral Liver enlargement, proliferation of SER, increase in number of microbodies and (7)
swelling of mitochondria with shortening of cristaea
Rat Oral Cloudy swelling, necrosis and enlargement of liver cells (11)
Mouse Oral Swollen mitochondria and increased SER' (13)
Ferret Oral Increase in liver weight, enlarged parenchymal cells not distributed uniformly, (12)
lysosomal changes and dilatation of SERa
Monkey IV Liver necrosis, inflammatory cell filtration, subtle changes in BSP clearance rate (14)
'SER = Smooth endoplasmic reticulum.
Table 2. Effect of phthalates on energy and carbohydrate metabolism.
Route of
Species administration Principal findings References
Rat Oral Mitochondrial swelling and decreased SDH activity (7)
Rat Oral Inhibition of glycolysis and decrease in glycogen content (24)
Rat IP Inhibition of SDH, ATPase, diaphorase and cytochrome-c oxidase activities (9,15,19)
Rat (In vitro) Mitochondrial swelling and stimulation of latent ATPase activity (16)
Rat (In vitro) Inhibition of mitochondrial respiration, and SDH activity (19)
Rat (In vitro) Inhibition of mitochondrial respiration (17,18)
Rat IP Decreased blood glucose tolerance, glycogen, glycogenesis and glycogenolysis; (25)
inhibition of glucose-6-phosphatase, phosphorylase and glucose-6-phosphate
dehydrogenase
Mouse Oral Decreased glycogen (13)
Ferret Oral Absence ofglycogen (12)
swelling and increase in microbodies in rat liver
havebeenreported on oral administration ofDEHP
for 21 days (7). Enlargement of cells, dilatation of
smoothendoplasmicreticulumand changesinhepatic
lysosomes of ferrets (12) and swollen mitochondria
and increased smooth endoplasmic reticulum in
liver of mice (13) receiving DEHP orally have also
been reported.
Very little information is available on the hepatic
effects ofphthalates in primates. Jacobson (14) has
reported liver necrosis and inflammatory cell in-
ifitrations in rhesus monkeys receiving plasma-
solubilized DEHP intravenously. Subtle changes in
the clearance time of sulfobromophthalein were
also observed (Table 1).
Effect of Phthalates on Energy
and Carbohydrate Metabolism
Associated with liver enlargement, changes
(increases or decreases) in many hepatic enzymes
have been reported in phthalate-exposed animals
(Table 2). A decrease in succinic dehydrogenase
(SDH) activity after oral or intraperitoneal admin-
istration of DEHP has been observed consistently
(7, 15). Histochemical studies have revealed that
loss ofthe enzyme occursspecificallyintheperiportal
zones (7).
Mitochondria appeartobethetargetofphthalates.
Adverse effects of phthalates on mitochondrial
functionhavebeenreportedbyseveralinvestigators.
In vitro studies have shown that several PAEs can
produce significant inhibition of mitochondrial res-
piration (16-18). The studies ofOhyama(16) suggest
that phthalates are electron and energy transport
inhibitors, while the observations of Inouye et al.
(10)indicatethatphthalatescanalsocauseuncoupling
ofoxidativephosphorylation. Phthalateswerefound
to produce aberrations in mitochondrial function,
e.g., di-n-butyl phthalate enhanced K+ efflux from
isolated mitochondria, usually not produced by
standard uncoupling agents (18). Sensitivity of
various components of electron transport chain
towards phthalates was indicated under in vivo
conditions as well as by decreased activities of
mitochondrial cytochrome-c oxidase, malic dehy-
drogenase and diaphorase in liverofDEHP-treated
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rats (9). The inhibition of these mitochondrial
enzymes also indicates an interaction of DEHP
with mitochondrial membranes.
DEHP was also found to inhibit the activity of
total and Mg'-stimulated adenosine triphosphatase
(ATPase) activity ofrat liver (9, 19). Besides liver,
the activity of SDH and ATPase was also inhibited
in rat heart, lung, kidney (19) and gonads (20),
indicatingthatsuppressionofenergy-linked reactions
may be a generalized effect of DEHP. In vivo
effects of DEHP (9, 15, 19) were present 11 days
after the final treatment with plasticizers. This
suggests that enzymic alterations were perhaps not
related to the physical presence of DEHP, as by
this time all of the plasticizer would have been
excreted (6, 21, 23).
Detailed studies have been conducted on the
effects ofDEHP oncarbohydrate metabolism (Table
2). A decrease in glycogen in livers of mice (13),
rats (19) and ferrets (12) receiving DEHP has been
reported. Sakurai et al. (24) showed marked
depression of glucose and glycogen in livers of rat
receiving a diet containing 2% or 4% DEHP.
Studies on the rates of incorporation of labeled
pyruvate into blood glucose and liver glycogen and
alteration in the levels of intermediates of carbo-
hydrate metabolism indicated retardation ofgluco-
neogenesis (24). Recent studies of Mushtaq et al.
(25) using cold and labeled glucose have shown that
DEHPinhibits bothglycogenesis andglycogenolysis
inratliver. These authorshave observed asignificant
decrease in the activity of glucose 6-phosphate
dehydrogenase, phosphorylase and glucose 6-phos-
phatase and no change in the activity of fructose
1,6-diphosphatase and aldolase in livers of DEHP-
exposed rats (25).
Effect of Phthalates on Lipid
and Protein Metabolism
Since the detection of DEHP in association with
triglycerides ofbeefmitochondria (26), itsinteraction
with lipid metabolism has been a subject of active
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investigation (Table 3). Stein et al. (27) showed an
interaction between dietary fat and DEHP in lipid
metabolism where presence ofthe phthalate in diet
potentiated the growth-promoting effect oflipids in
rats. Substantial reduction in serum cholesterol and
proliferationofperoxisomesandelevationofcatalase
and carnitine acetyltransferase activity in livers of
animals receiving DEHP via diet was reported by
Reddy et al. (28). Induction of the fatty acyl-CoA
oxidizing enzyme system located in peroxisomes by
DEHPhasbeen suggestedby Osumiand Hashimoto
(29), and inhibition of lipid synthesis in rats has
been shown by Bell et al. (30, 31). Reduced serum
glucose and cholesterol and elevated serum free
fatty acid and ketone body have also been reported
(26, 32, 33). The rats receiving 0.5% of DEHP in a
normal protein diet showed accumulation of phos-
pholipids, decrease in cholesterol and triglyceride
contents in liver and a rise in levels ofplasma fatty
acids. Such observations suggest the utilization of
lipidsforthe energy source. However, thesignificance
of this altered state of energy metabolism is not
understood at present (Table 3).
No significant studies have been conducted on
the effects of phthalate on protein metabolism,
thoughtheireffects ontheotherproximateprinciples,
carbohydrate and fat have been studied in detail.
An increase in the protein content in liver of
DEHP-treated rats has been described byYanagita
et al. (32). Recently Pillai et al. (34) have shown
that a DEHP-caused elevation in rat liver protein
content is due to a decrease in protein breakdown
(Table 3).
Interaction of Phthalates with
Other Xenobiotics
Alterations in barbiturate sleeping time on ex-
posure to phthalates have been reported by several
investigators. Asingleintraperitoneal orintravenous
injection of DEHP was found to increase the
hexobarbital or pentobarbital sleeping time in rats
or mice (6, 35-37). Repeated intraperitoneal ad-
Table 3. Effect of DEHP on lipid and protein metabolism.
Route of
Species administration Principal findings References
Rat Oral II '-bition oflipid biosynthesis (30,31)
Rat IP Decrease in cholesterol content (9)
Rat Oral Decrease in triglycerides and increase in phospholipids (24)
Rat, mouse Oral Decrease in serum cholesterol; proliferation of peroxisomes; increase of catalase (28)
and carnitine acetyltransferase
Rat, mouse Oral Induction of enzymes offatty acyl-CoA ,B-oxidation (29)
Rat Oral Increase in mitochondrial and microsomal phospholipids; increase in protein (32,35)
content
Rat Oral Increase in protein content (decrease in protein degradation) (34)30
ministration of a number of phthalates caused sig-
nificant and dose-dependent increases in pento-
barbital sleeping time in mice (38), while repeated
oral administration of DEHP resulted in reduced
hexobarbital sleeping time in rats (6).
DEHPhasalsobeenshowntomodifythebiological
response of parathion, an organophosphorus in-
secticide (39). Parathion exerts its toxic effect
through its metabolite, paraxon, which is a potent
inhibitor ofacetylcholine esterase enzyme. A lower
inhibitory activity of parathion in DEHP-treated
rats suggested an effect of the phthalate on
biotransformation of the pesticide to its active
metabolite (39). Alterations inthebiological response
of carbon tetrachloride (40) and ethanol (41) have
also been described.
The mechanism by which phthalates modify the
biologicalresponseoftheabove-mentionedxenobiotics
is not clear, although some investigators have
suggested alterations in the biodistribution and
biotransformation of the test xenobiotics or an
increase in sensitivity ofthe central nervous system
towards them in the presence of phthalates (6,
36-39). Estimation of concentration of barbiturates
in blood during sleep and at awakening have shown
that sleeping time alterations caused by DEHP
were related to retarded disposition of the test
drugs and not to the increased sensitivity of the
central nervous system (36, 38). An increase in
hepatic cytochrome P-450 content, alcohol dehy-
drogenaseactivityandpersistentinhibition ofaniline
hydroxylase activity in livers of rats receiving
DEHPforprolongedperiodsindicatesitsinteraction
with biotransformation mechanism.
In view of the significance of this aspect of
phthalate toxicity and variable effects ofphthalates
on barbiturate and ethanol-induced sleeping time,
the effect of DEHP on some enzymes involved in
their biotransformation will be discussed in detail.
Effect of DEHP on Enzymes
Involved in Biotransformation of
Ethanol and Other Xenobiotics
The effect ofDEHP onthe activity ofaminopyrine
N-demethylase or aniline hydroxylase is shown in
Figure 1. A single oral or intraperitoneal exposure
to DEHP caused a significant dose-dependent de-
crease in aminopyrine N-demethylase and aniline
hydroxylase activity and no change in cytochrome
P-450 content (datanot shown). Exposureto DEHP
for 7 days produced a differential effect. Activity of
these two microsomal enzymes was significantly
increased upon oral administration but remained
decreased upon intraperitoneal administration. Re-
peated oral administration also increased the levels
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FIGURE 1. Effect of di(2-ethylhexyl) phthalate (DEHP) on
aminopyrine N-demethylase (A. demethylase) and aniline
hydroxylase (A. hydroxylase) activity of rat liver. Adult
male albino rats were treated with 1/10, 1/5 and 1/2 of the
LD ia tdose of DEHP orally (LD.0 = 26 g/kg) by gavage or
intraperitoneally(LD5O = 50mllkg)once ordailyup to 7days.
These dosesare known tocause teratogenic (42), pharmacologic
(38) and biochemical (7-9, 15, 19, 20) effects.
of cytochrome P-450 which were not altered upon
single oral administration (data not shown). Cyto-
chrome P-450 levels were also not affected by
repeated intraperitoneal administration of DEHP.
Inorderto see whetherthe alterations inactivities
of aminopyrine N-demethylase and aniline hydro-
xylase are caused by DEHP or its two active
metabolites, their effects on these two enzymes
wereinvestigated invitro atvaryingconcentrations.
DEHPhadnoeffect onaminopyrineN-demethylase
(Fig. 2) or aniline hydroxylase activity (Fig. 3),
while mono(2-ethylhexyl) phthalate (MEHP) and
2-ethylhexanol(2-EH)producedsignificantinhibition
at concentrations ranging from 2.5 to 15mM.
The effects of DEHP on activity ofalcohol dehy-
drogenase and high and low Km aldehyde dehy-
drogenases are shown in Figures 4 and 5. A single
oral administration ofDEHP significantly inhibited
the activity of alcohol dehydrogenase in a dose-
dependent manner while intraperitoneal adminis-
tration produced the effect only at the highest dose.
No effect ofDEHP was observed on the activity of
high or low Km aldehyde dehydrogenase after a
single oral or intraperitoneal administration (Fig.8Uo DEHP 80
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FIGURE 2. In vitro effect of di(2-ethylhexyl) phthalate (DEHP), mono(2-ethylhexyl) phthalate (MEHP) and 2-ethylhexanol
(2-EH) on the activity of aminopyrine N-demethylase of rat liver. These compounds were added directly into the incubation
mixture and the effect was studied without any preincubation with enzyme preparation.
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FIGURE 3. In vitro effect of di(2-ethylhexyl) phthalate (DEHP), mono(2-ethylhexyl) phthalate (MEHP) an(d 2-ethylhexanol (2-EH)
on the rat liver aniline hydroxylase activity. Conditions of assay as described in Fig. 2.
HEPATOTOXICITY OF PHTHALATES 3132
4). The repeated oral administration of DEHP
produced a different effect than that seen after a
single administration ofthephthalate. Theactivities
ofalcohol and aldehyde dehydrogenases were signi-
ficantlyincreased. However,repeatedintraperitoneal
administration ofDEHP caused no significant change
in the activity of these enzymes (Fig. 5).
The above results suggest that DEHP produces a
time- and route-dependent effect onthe activities of
aminopyrine N-demethylase, aniline hydroxylase,
cytochrome P450content andalcoholdehydrogenase
and high and low Km aldehyde dehydrogenases. A
similar time- and route-dependent effect of DEHP
was seen on the pentobarbital (43) and ethanol (44)
sleeping time in rats and mice, respectively. An
increase in hexobarbital sleeping time after intra-
peritoneal orintravenous administration and decrease
in the same after repeated oral administration have
alsobeenobservedbyDanielandBratt(6). However,
no suitable explanation has been provided by these
investigators. DEHP is hydrolyzed to MEHP at
markedlydifferentratesbyintestineandliverlipases
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FIGURE 4. Effect of DEHP on alcohol dehydrogenase (ADH),
high Km aldehyde dehydrogenase (ACDH high Km) and low
Km aldehyde dehydrogenase (ACDH low Km). Adult male
Swiss mice were treated with 1/10, 1/5 and 1/2 LD50 dose
orally (LD5, = 40 ml/kg) by gavage, and enzyme activities
were measured in liver 18 hr after the treatment.
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(21, 45, 46) and metabolized to 2-EH. These two
major metabolites of DEHP have been reported to
mimic some ofthe biological effects ofplasticizer (7,
16, 33). Thus, the above observed route-dependent
effects of DEHP may perhaps be related to the
amounts ofMEHP and 2-EH formed in the body, as
oral administration of the phthalate may result in
higher concentrations of these metabolites.
A significant inhibition of aminopyrine N-de-
methylase and aniline hydroxylase by MEHP and
2-EH without anyeffect ofDEHP onthese enzymes
under in vitro conditions suggests that these two
metabolites are responsible fortheir in vivo effects.
TheDEHP-induced alterationsinethanolmetabolism
may also be related to MEHP and 2-EH, as these
metabolites can be generated both by mitochondria
and microsomes (45). Such observations are ofgreat
significance in view of a recent report on the meta-
bolism ofDEHP and accumulation ofitsmetabolites
in human blood and red cell concentrates stored in
PVC blood bags (47).
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FIGURE 5. Effect of DEHP on alcohol dehydrogenase (ADH),
high Kn, aldehyde dehydrogenase (ACDH high Kin) and low
K.. aldehyde dehydrogenase (ACDH low Kin,) activity of
mice liver. Adult male Swiss mice were given three different
doses of DEHP as described in Fig. 5 daily for 7 days, and
enzyme activities weremeasured 18hrafterthe last treatment.
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Effect of Dimethyl Phthalate (DMP)
and Dibutyl Phthalate (DBP) on
Drug-Metabolizing Enzymes
In order to compare the effects of DMP with
DEHP onthe activityofaminopyrine N-demethylase
and aniline hydroxylase, male rats were exposed to
these phthalates at a concentration corresponding
to 1/10 oftheir LD50 dose by intraperitoneal route.
The activity of these enzymes was examined 18 hr
afterthe administration ofphthalates. All the three
phthalates inhibited the activity of aminopyrine
N-demethylase and aniline hydroxylase with DMP
producing the maximum effect followed by DEHP
and DBP(Fig. 6). The effect ofDBP onaminopyrine
N-demethylase was, however, not significant.
The above results show that besides DEHP,
these two phthalates can also inhibit the activity of
drug-metabolizing enzymes and hence can modify
the biological response ofcertain xenobiotics. These
phthalates failed to exhibit any structure-activity
relationship in affecting the activity ofaminopyrine
N-demethylase and aniline hydroxylase. A similar
observation on the lack of any role of molecular
structureofphthalatesinprolongingthepentobarbital
sleeping time (38) or inhibiting the growth ofnerve
cell fibroblasts (48) has been reported earlier.
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FIGURE 6. Effect of di(2-ethylhexyl) phthalate (DEHP),
dimethyl phthalate (DMP) and dibutyl phthalate (DBP) on
aminopyrine N-demethylase (A. demethylase) and aniline
hydroxylase (A. hydroxylase) activity of rat liver. Adult
male albino rats were given DEHP, DMP, and DBP (5.0, 3.6
and 3.05 ml/kg, respectively) by intraperitoneal route, and
enzyme activities were measured 18 hr after the treatment.
Conclusions
DEHP at high concentrations can cause func-
tionalhepaticdamage, asreflectedbymorphological
changes, and alterations in the activity of energy-
linked enzymes and metabolism of lipids and car-
bohydrates. Phthalates can interact with other
xenobiotics and such interactions occur during the
pharmacokinetic phase. These observations are of
significance, as man may be exposed to low levels of
phthalates for prolonged periods which can cause
altered drug-xenobiotic reactions. Effects ofDEHP
aredose- androute-dependent and arealsoinfluenced
by strain and species ofthe test animal. At present,
information on the biological effects ofphthalates in
higher animals is very limited.
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